Literature DB >> 7586208

Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?

G Thordarson1, E Jin, R C Guzman, S M Swanson, S Nandi, F Talamantes.   

Abstract

Administration of a single i.v. injection of 50 mg N-methyl-N-nitrosourea (MNU)/kg body wt to 50- to 60-day old virgin rats, 120-day-old virgin rats, and 120-day-old parous rats (Sprague-Dawley; n = 18-37) resulted in a high incidence of mammary carcinomas in the virgin animals (97.3% in 50- to 60-day-old virgin rats; 75.0% in 120-day-old virgin rats), but mammary carcinomas did not develop in the parous rats. The concentrations in serum of various mammotropic hormones were measured in identical groups of rats at the time of MNU treatment. Growth hormone (GH) concentration was significantly reduced in parous rats, as compared with young or age-matched virgin rats. The concentrations of prolactin, 17 beta-estradiol, progesterone, corticosterone and thyroxine were not significantly altered in the parous rats compared to the two groups of virgin animals. Histological examination of the mammary glands from the three groups of rats showed that the epithelia of the parous animals were in a stage of regression, whereas the mammae of the young virgin rats showed the highest degree of lobulo-alveolar development. The levels of estrogen receptor (ER), epidermal growth factor (EGF) receptor (EGF-R) and GH receptor (GHR) in the mammary glands of the animals were also measured. We found a reduction in the receptor levels for both estrogen and EGF in mammary tissues from parous animals. Receptors for GH were present in normal mammary tissues from both virgin and parous rats. We hypothesize that the reduction in the circulating concentration of GH caused the reduced susceptibility of parous rats to mammary carcinogenesis possibly by decreasing the levels of ER and/or EGF-R in the mammary gland.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586208     DOI: 10.1093/carcin/16.11.2847

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  35 in total

Review 1.  Hormone-induced protection against breast cancer.

Authors:  Lakshmi Sivaraman; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

2.  17β-Estradiol alters oxidative damage and oxidative stress response protein expression in the mouse mammary gland.

Authors:  Lisi Yuan; Alicia K Dietrich; Yvonne S Ziegler; Ann M Nardulli
Journal:  Mol Cell Endocrinol       Date:  2016-02-09       Impact factor: 4.102

Review 3.  New biological insights on the link between radiation exposure and breast cancer risk.

Authors:  Mary Helen Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-01-17       Impact factor: 2.673

Review 4.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

5.  p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis.

Authors:  L Sivaraman; O M Conneely; D Medina; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

6.  Decreasing hormonal promotion is key to breast cancer prevention.

Authors:  Lakshmanaswamy Rajkumar; Amy Canada; David Esparza; Katherine Collins; Enrique Moreno; Huyen Duong
Journal:  Endocrine       Date:  2009-02-12       Impact factor: 3.633

7.  Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.

Authors:  Huiyan Ma; Katherine D Henderson; Jane Sullivan-Halley; Lei Duan; Sarah F Marshall; Giske Ursin; Pamela L Horn-Ross; Joan Largent; Dennis M Deapen; James V Lacey; Leslie Bernstein
Journal:  Breast Cancer Res       Date:  2010-06-18       Impact factor: 6.466

8.  Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells--implications for pregnancy-induced protection against breast cancer.

Authors:  Stefan K Siwko; Jie Dong; Michael T Lewis; Hao Liu; Susan G Hilsenbeck; Yi Li
Journal:  Stem Cells       Date:  2008-09-11       Impact factor: 6.277

9.  Inter-Individual Variation in Response to Estrogen in Human Breast Explants.

Authors:  Karen A Dunphy; Amye L Black; Amy L Roberts; Aman Sharma; Zida Li; Sneha Suresh; Eva P Browne; Kathleen F Arcaro; Jennifer Ser-Dolansky; Carol Bigelow; Melissa A Troester; Sallie S Schneider; Grace Makari-Judson; Giovanna M Crisi; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-03-09       Impact factor: 2.673

10.  Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells.

Authors:  Kara L Britt; Howard Kendrick; Joseph L Regan; Gemma Molyneux; Fiona-Ann Magnay; Alan Ashworth; Matthew J Smalley
Journal:  Breast Cancer Res       Date:  2009-04-23       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.